This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
Kerry Hotel Pudong
April 23–24, 2025 | Shanghai, ChinaApril 29–30, 2025 | Virtual
Book Now
Menu
Book Now

Wheeseong Lee
CEO/Founder at Lmito Therapeutics
Presenter

Profile

Lmito develops a novel therapy for autoimmune disorders through a modulation of immunometabolism including a macrophage polarization. In the fibrotic context, LMT compounds exert the anti-fibrotic effects through metabolic reprogramming of profibrotic cells in PF-ILD and IPF.

Agenda Sessions

  • Autoimmune/Inflammation: Lmito Therapeutics

    , 15:30
    View Session

At this event

Prev
Next
Yiming Liu
Partner in Charge - Shanghai
Cooley LLP

See Wheeseong at ChinaBio® Partnering Forum

Book Now